Cancer Research · 2005 · 43 citations · 32 references
Life SciencesCancer BiologyOncologyCancer GeneticsGene ExpressionMolecular OncologyB Cell DevelopmentGerminal Center ReactionsLymphocyte DevelopmentLymphoid NeoplasmsLymphoid TumorsGerminal Center AbnormalitiesGerminal Center BiologyImmunohistochemical MarkersImmunohistochemical StainingLymphoid Neoplasm PathogenesisLymphoma PathogenesisPromoter ControlTransgenic Mice
Lymphomas arise containing abnormalities of various differentiation stage-specific molecules. In the study reported here, we have shown abnormal up-regulation of germinal center B cell-associated GANP in various human lymphomas including mantle cell, diffuse large B cell, and Hodgkin lymphoma, by immunohistochemical analysis. To study the role of GANP in lymphomagenesis, we generated mutant mice (ganp-Tg) that express the transgenic ganp gene under immunoglobulin enhancer and promoter control. Ganp-Tg mice showed a high incidence of lymphomagenesis (29.5%) after aging with a non-B/non-T cell surface phenotype having slight CD45R/B220 expression and Ig transcripts of rearranged VH-DH-JH IgH loci. Lymphomas generated in ganp-Tg mice displayed similar pathologic characteristics to mouse reticulum cell neoplasm or Hodgkin lymphoma-like lesions. The VH sequences of individual mice showed that the tumors proliferated from a single clone or oligoclones, as is found in human diffuse large B-cell lymphomas and Hodgkin lymphoma. These results suggest that GANP overexpression is a causative factor in the generation of B lymphomas.
32
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Jerry M. Adams, A. W. Harris, Carl A. Pinkert et al. · Nature · 1985 · 1.8K citations
Holger Kanzler, Ralf Küppers, Martin‐Leo Hansmann et al. · The Journal of Experimental Medicine · 1996 · 757 citations · Full text